Cochrane2023IaEN
Cochrane Review: Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD)
Zusammenfassung
Pharmakologische Interventionen gegen Reizbarkeit, Aggressivität und Selbstverletzung bei Autismus‐Spektrum‐Störungen (ASS) - Iffland, M - 2023 \| Cochrane Library
[Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011769.pub2/full/de#main-content)
[Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011769.pub2/full/de#)
Cookies
Our site uses cookies to improve your experience. You can find out more about our use of cookies in About
Kerninformationen
51858.CD011769.pub2/full/de#)
[Cochrane Database of Systematic reviews](https://www.cochranelibrary.com/en/about/about-cochrane-reviews) Review - Intervention
Collapse all Expand all
## Abstract
available in
### Background
Pharmacological interventions are frequently used for people with auti...
ers up to June 2022. We also searched reference lists of relevant studies, and contacted study authors, experts and pharmaceutical companies.
### Selection criteria
We included randomised controlled trials of participants of any age with a clinical diagnosis of ASD, that compared any pharmacologic...
We included 131 studies involving 7014 participants in this review. We identified 26 studies as awaiting classification and 25 as ongoing. Most studies involved children (53 studies involved only children under 13 years), children and adolescents (37 studies), adolescents only (2 studies) children a...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
Cochrane2025
Cochrane Review: Atypical antipsychotics for autism spectrum disorder: a network meta-analysis
Cochrane2023
Cochrane Review: Acetylcholinesterase inhibitors for autistic spectrum disorders
Cochrane2024
Cochrane Review: Cognitive behavioural therapy without medication for schizophrenia
Cochrane2022
Cochrane Review: Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Cochrane2022
Cochrane Review: Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms
Cochrane2021
Cochrane Review: Anti-seizure medications for Lennox-Gastaut syndrome
Cochrane2023
Cochrane Review: Pharmacological treatments in panic disorder in adults: a network meta-analysis
Cochrane2019